{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:03:45Z","timestamp":1791669825254,"version":"4.3.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2019,1,30]]},"DOI":"10.3233\/jnd-180346","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T10:38:30Z","timestamp":1546598310000},"page":"31-41","source":"Crossref","is-referenced-by-count":29,"title":["Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations"],"prefix":"10.1177","volume":"6","author":[{"given":"Sasigarn A.","family":"Bowden","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Nationwide Children\u2019s Hospital\/The Ohio State University College of Medicine, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathi","family":"Kinnett","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Hackensack, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Zeitler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology, University of Colorado School of Medicine, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JND-180346_ref1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.39.4.475","article-title":"Duchenne muscular dystrophy Patterns of clinical progression and effects of supportive therapy","volume":"39","author":"Brooke","year":"1989","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JND-180346_ref2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.3233\/JND-180346_ref3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscular disorders: NMD"},{"issue":"3","key":"10.3233\/JND-180346_ref4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2014-2044","article-title":"Prevalence of Duchenne and Becker muscular dystrophies in the United States","volume":"135","author":"Romitti","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.3233\/JND-180346_ref5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.3233\/JND-180346_ref6","doi-asserted-by":"crossref","unstructured":"Moxley RT , Pandya S , Ciafaloni E , Fox DJ , Campbell K . Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. Journal of Child Neurology. 2010.","DOI":"10.1177\/0883073810371004"},{"issue":"4","key":"10.3233\/JND-180346_ref7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.24346","article-title":"Outcome reliability in non-Ambulatory Boys\/Men with duchenne muscular dystrophy","volume":"51","author":"Connolly","year":"2015","journal-title":"Muscle & Nerve"},{"key":"10.3233\/JND-180346_ref8","doi-asserted-by":"crossref","unstructured":"Matthews E , Brassington R , Kuntzer T , Jichi F , Manzur AY . Corticosteroids for the treatment of Duchenne muscular dystrophy. The Cochrane Library. 2016.","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"10.3233\/JND-180346_ref9","volume-title":"Mayo Clinic Proceedings","author":"Drozdowicz","year":"2014"},{"issue":"5","key":"10.3233\/JND-180346_ref10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-180346_ref11","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2006-1612","article-title":"Adrenal insufficiency: still a cause of morbidity and death in childhood","volume":"119","author":"Shulman","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.3233\/JND-180346_ref12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amjmed.2015.08.021","article-title":"Adrenal crisis: still a deadly event in the 21st century","volume":"129","author":"Puar","year":"2016","journal-title":"The American Journal of Medicine"},{"key":"10.3233\/JND-180346_ref13","first-page":"9","article-title":"The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal Suppression","author":"Kinnett","year":"2017","journal-title":"PLoS Currents"},{"issue":"6","key":"10.3233\/JND-180346_ref14","first-page":"1505","article-title":"Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis","volume":"76","author":"Kerrigan","year":"1993","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.3233\/JND-180346_ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"18","key":"10.3233\/JND-180346_ref16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199710303371807","article-title":"Corticosteroid therapy in severe illness","volume":"337","author":"Wood","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.3233\/JND-180346_ref17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199710303371807","article-title":"Corticosteroid therapy in severe illness","volume":"337","author":"Lamberts","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.3233\/JND-180346_ref18","first-page":"12","article-title":"Supplemental perioperative steroids for surgical patients with adrenal insufficiency","author":"Yong","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.3233\/JND-180346_ref19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-180346_ref20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function","volume":"63","author":"Meikle","year":"1977","journal-title":"The American Journal of Medicine"},{"issue":"5","key":"10.3233\/JND-180346_ref21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/BF02877711","article-title":"Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity","volume":"24","author":"Gonzalez-Perez","year":"2007","journal-title":"Advances In Therapy"},{"issue":"7","key":"10.3233\/JND-180346_ref22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.282.7.671","article-title":"Glucocorticoid-induced adrenal insufficiency","volume":"282","author":"Krasner","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.3233\/JND-180346_ref23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jpeds.2013.01.011","article-title":"A Search for Variables Predicting Cortisol Response to Low-Dose Corticotropin Stimulation Following Supraphysiological Doses of Glucocorticoids","volume":"163","author":"Wildi-Runge","year":"2013","journal-title":"The Journal of Pediatrics"},{"issue":"8","key":"10.3233\/JND-180346_ref24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"10.3233\/JND-180346_ref25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mpd.2000.107385","article-title":"Time course of recovery of adrenal function in children treated for leukemia","volume":"137","author":"Felner","year":"2000","journal-title":"The Journal of Pediatrics"},{"key":"10.3233\/JND-180346_ref26","unstructured":"Goldbloom EB , Mokashi A , Cummings EA , Abish S , Benseler SM , Huynh HQ , et al., Symptomatic adrenal suppression among children in Canada. Archives of Disease in Childhood. 2016:archdischild-2016-311223."},{"issue":"5","key":"10.3233\/JND-180346_ref27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpeds.2005.06.006","article-title":"Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test","volume":"147","author":"Rix","year":"2005","journal-title":"The Journal of Pediatrics"},{"issue":"1","key":"10.3233\/JND-180346_ref28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/adc.87.1.45","article-title":"Cushing\u2019s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids","volume":"87","author":"Perry","year":"2002","journal-title":"Archives of Disease in Childhood"},{"issue":"11","key":"10.3233\/JND-180346_ref29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3949\/ccjm.78a.10180","article-title":"Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them","volume":"78","author":"Lansang","year":"2011","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"17","key":"10.3233\/JND-180346_ref30","doi-asserted-by":"crossref","first-page":"E1030","DOI":"10.1097\/BRS.0000000000001534","article-title":"Impact of a Comparative Study on the Management of Scoliosis in Duchenne Muscular Dystrophy: Are Corticosteroids Decreasing the Rate of Scoliosis Surgery in the United States?","volume":"41","author":"Raudenbush","year":"2016","journal-title":"Spine"},{"key":"10.3233\/JND-180346_ref31","doi-asserted-by":"crossref","unstructured":"Lebel DE , Corston JA , McAdam LC , Biggar WD , Alman BA . Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up. The Journal of Bone & Joint Surgery. 2013;95(12):1057\u201361.","DOI":"10.2106\/JBJS.L.01577"},{"issue":"9","key":"10.3233\/JND-180346_ref32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0883073816650034","article-title":"Fracture in Duchenne muscular dystrophy: natural history and vitamin D deficiency","volume":"31","author":"Perera","year":"2016","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.3233\/JND-180346_ref33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jpainsymman.2006.08.013","article-title":"The steroid withdrawal syndrome: a review of the implications, etiology, and treatments","volume":"33","author":"Margolin","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"12","key":"10.3233\/JND-180346_ref34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1651-2227.2010.01936.x","article-title":"Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases","volume":"99","author":"Huber","year":"2010","journal-title":"ACTA Paediatrica"},{"issue":"5","key":"10.3233\/JND-180346_ref35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JND-180346_ref36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mus.25089","article-title":"Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA\u2013DMD network follow-up","volume":"54","author":"Connolly","year":"2016","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.3233\/JND-180346_ref37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.201703-0507WS","article-title":"Pulmonary Endpoints in Duchenne Muscular Dystrophy","volume":"196","author":"Finder","year":"2017","journal-title":"A Workshop Summary. American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.3233\/JND-180346_ref38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0889-8529(02)00008-7","article-title":"Glucocorticoid withdrawal schemes in chronic medical disorders: A systematic review","volume":"31","author":"Richter","year":"2002","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"1","key":"10.3233\/JND-180346_ref39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/jcem-25-1-11","article-title":"Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids","volume":"25","author":"Graber","year":"1965","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.3233\/JND-180346_ref40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1987.tb00780.x","article-title":"Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency","volume":"26","author":"H\u00e4gg","year":"1987","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.3233\/JND-180346_ref41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/eje.0.1390567","article-title":"The role of high-and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency","volume":"139","author":"Oelkers","year":"1998","journal-title":"European Journal of Endocrinology"},{"issue":"10","key":"10.3233\/JND-180346_ref42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0960-8966(02)00180-3","article-title":"High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy","volume":"12","author":"Connolly","year":"2002","journal-title":"Neuromuscular Disorders"},{"issue":"5","key":"10.3233\/JND-180346_ref43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00415-009-5012-y","article-title":"Prednisone 10 days on\/10 days off in patients with Duchenne muscular dystrophy","volume":"256","author":"Straathof","year":"2009","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.3233\/JND-180346_ref44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.3233\/JND-180346_ref45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.287.2.236","article-title":"Corticosteroid supplementation for adrenal insufficiency","volume":"287","author":"Coursin","year":"2002","journal-title":"JAMA"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-180346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:36Z","timestamp":1777506816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-180346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jnd-180346","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}